Progyny has retired 20.5% of its shares since 2023, from 96,499,402 to 76,726,798.
At $26.86 a share, a market value of $2.1B. FCF yield 8.7%, P/E 26.2, trailing twelve months to June 2026.
| Fiscal year | Date | Shares outstanding | Filing | |
|---|---|---|---|---|
| 2019 | 2020-02-28 | 84,838,934 | 10-K | |
| 2020 | 2021-01-31 | 87,215,936 | 10-K | |
| 2021 | 2022-01-31 | 91,234,747 | 10-K | |
| 2022 | 2023-01-31 | 93,378,243 | 10-K | |
| 2023 | 2024-01-31 | 96,499,402 | 10-K | |
| 2024 | 2025-01-31 | 85,413,283 | 10-K | |
| 2025 | 2026-01-31 | 81,902,232 | 10-K |
Source: all 10-K filings of Progyny on EDGAR. Download this series as CSV. Licence CC BY 4.0, credit Buyback Radar.
Cash spent comes from the cash flow statement. Shares outstanding fell by less than the company bought, because part of every buyback only replaces shares handed to employees. Today’s price is $26.86.
Loading the chart from TradingView…
All-time chart by TradingView. Open it on TradingView →
Yes. Progyny has 11.0% fewer shares outstanding than twelve months ago, 76,726,798 as of July 31, 2026. Over five years the share count is down 15.2%.
Net of every new share it issued, Progyny has 19.8 million fewer shares than at its 2023 peak. That is 20.5% of the company.
76,726,798 shares, as of July 31, 2026, from the cover page of its latest 10-Q. At the 2023 peak it had 96,499,402.
Each share is a bigger slice of the company. Someone who held Progyny stock in 2023 owns 1.3 times as much of the business today without buying another share. Whether that was a good use of cash depends on the price paid.
Progyny ranks No. 368 of 467 companies on Buyback Radar by share of the company retired since its peak. Close to it on the list: Huntington Ingalls Industries (20.6%), Kaiser Aluminum (20.6%), Baxter International (20.4%), Essent Group (20.4%).
Every answer is computed from Progyny's own SEC filings and rebuilt every Monday. Latest count: 10-Q on EDGAR.
From the latest 13F filings. All superinvestors.
The numbers say what happened. The story says whether it can continue. We cover companies like Progyny in depth on Cannibal Stocks.
Read Cannibal Stocks